• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性结直肠肉瘤的预后因素及阴性淋巴结清扫的临床结局

The prognostic factors of primary colorectal sarcoma and the clinical outcomes of negative lymph node dissection.

作者信息

Wei Zhewen, Mao Rui, Zhang Yefan, Bi Xinyu, Zhou Jianguo, Li Zhiyu, Huang Zhen, Chen Xiao, Zhao Jianjun, Zhao Hong, Cai Jianqiang

机构信息

Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Ann Transl Med. 2021 Feb;9(3):250. doi: 10.21037/atm-20-4286.

DOI:10.21037/atm-20-4286
PMID:33708877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7940912/
Abstract

BACKGROUND

Primary colorectal sarcoma is an extremely rare malignancy that is associated with poor patient outcomes. The aim of this study was to identify the prognostic factors of primary colorectal sarcoma and evaluate the clinical outcomes associated with these prognostic factors.

METHODS

Between January 1, 2000 and December 31, 2016, the clinical data of 315 patients with primary colorectal sarcoma were obtained from the Surveillance, Epidemiology, and End Results (SEER) database. Cancer-specific survival (CSS) was analyzed by the Kaplan-Meier method and by log-rank test. The prognostic factors were identified by univariate and multivariate Cox regression analysis and hazard ratio (HR) and 95% confidence interval (CI) of covariates were also estimated. The optimal cutoff value for NLN count at dissection was identified using X-tile software and validated by univariate Cox regression analysis.

RESULTS

Of the 315 patients with primary colorectal sarcoma identified, 88.6% received surgery. The median follow-up time was 34 months with an interquartile range (IQR) of 9-79 months. The 5-year rate of CSS was 76.73% and 27.8% for the surgery group and the non-surgery group, respectively (P<0.0001). Univariate and multivariate Cox regression analysis performed on the data of nonmetastatic patients demonstrated that sex, race, radiotherapy, and chemotherapy had no effect on patient CSS, with age, tumor site, tumor grade, and NLN dissection being independent prognostic factors. A significant correlation was found between advanced age (>80 years old) and poor CSS (HR 1.964; 95% CI: 1.005-3.839; P=0.048). There were also significant correlations between colonic tumors and poor CSS (HR 2.903; 95% CI: 1.348-6.250; P=0.006) and grade IV tumors and poor CSS (HR 3.431; 95% CI: 1.725-6.823; P<0.001), while NLN dissection was associated with improved CSS (HR 0.946; 95% CI: 0.911-0.983; P=0.004). X-tile software analysis was used to determine that the optimal cutoff value for NLN count was 13. Patients who received NLN dissection with a cutoff value of 13 or more displayed better CSS than those who did not (P=0.016).

CONCLUSIONS

Primary colorectal sarcoma patients can benefit significantly from primary tumor surgery. Age, tumor site, grade and NLN dissection are independent prognostic factors for CSS in nonmetastatic patients. Importantly, nonmetastatic patients treated with NLN dissection with an NLN count of 13 or more have significantly better CSS.

摘要

背景

原发性结直肠肉瘤是一种极其罕见的恶性肿瘤,与患者的不良预后相关。本研究的目的是确定原发性结直肠肉瘤的预后因素,并评估与这些预后因素相关的临床结局。

方法

在2000年1月1日至2016年12月31日期间,从监测、流行病学和最终结果(SEER)数据库中获取了315例原发性结直肠肉瘤患者的临床数据。采用Kaplan-Meier法和对数秩检验分析癌症特异性生存率(CSS)。通过单因素和多因素Cox回归分析确定预后因素,并估计协变量的风险比(HR)和95%置信区间(CI)。使用X-tile软件确定解剖时NLN计数的最佳临界值,并通过单因素Cox回归分析进行验证。

结果

在确定的315例原发性结直肠肉瘤患者中,88.6%接受了手术。中位随访时间为34个月,四分位间距(IQR)为9 - 79个月。手术组和非手术组的5年CSS率分别为76.73%和27.8%(P<0.0001)。对非转移性患者的数据进行单因素和多因素Cox回归分析表明,性别、种族、放疗和化疗对患者CSS无影响,年龄、肿瘤部位、肿瘤分级和NLN解剖是独立的预后因素。发现高龄(>80岁)与不良CSS之间存在显著相关性(HR 1.964;95% CI:1.005 - 3.839;P = 0.048)。结肠肿瘤与不良CSS(HR 2.903;95% CI:1.348 - 6.250;P = 0.006)以及IV级肿瘤与不良CSS(HR 3.431;95% CI:1.725 - 6.823;P<0.001)之间也存在显著相关性,而NLN解剖与CSS改善相关(HR 0.946;95% CI:0.911 - 0.983;P = 0.004)。X-tile软件分析确定NLN计数的最佳临界值为13。接受NLN解剖且临界值为13或更高的患者显示出比未接受者更好的CSS(P = 0.016)。

结论

原发性结直肠肉瘤患者可从原发性肿瘤手术中显著获益。年龄、肿瘤部位、分级和NLN解剖是非转移性患者CSS的独立预后因素。重要的是,接受NLN解剖且NLN计数为13或更多的非转移性患者具有显著更好的CSS。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafc/7940912/205acb686672/atm-09-03-250-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafc/7940912/40fdd20170e8/atm-09-03-250-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafc/7940912/864a900eeecd/atm-09-03-250-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafc/7940912/95d397b213d6/atm-09-03-250-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafc/7940912/205acb686672/atm-09-03-250-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafc/7940912/40fdd20170e8/atm-09-03-250-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafc/7940912/864a900eeecd/atm-09-03-250-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafc/7940912/95d397b213d6/atm-09-03-250-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eafc/7940912/205acb686672/atm-09-03-250-f4.jpg

相似文献

1
The prognostic factors of primary colorectal sarcoma and the clinical outcomes of negative lymph node dissection.原发性结直肠肉瘤的预后因素及阴性淋巴结清扫的临床结局
Ann Transl Med. 2021 Feb;9(3):250. doi: 10.21037/atm-20-4286.
2
Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.基于阴性淋巴结的列线图构建及其在非小细胞肺癌术后患者生存预测中的验证。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221074506. doi: 10.1177/15330338221074506.
3
The prognostic value of negative lymph node count for patients with cervical cancer after radical surgery.根治性手术后阴性淋巴结计数对宫颈癌患者的预后价值。
Oncotarget. 2017 Dec 21;9(2):2810-2818. doi: 10.18632/oncotarget.23596. eCollection 2018 Jan 5.
4
Critical prognostic value of the log odds of negative lymph nodes/tumor size in rectal cancer patients.直肠癌患者阴性淋巴结对数比/肿瘤大小的关键预后价值。
World J Clin Cases. 2021 May 26;9(15):3531-3545. doi: 10.12998/wjcc.v9.i15.3531.
5
Negative lymph node count is a significant prognostic factor in patient with stage IV gastric cancer after palliative gastrectomy.阴性淋巴结计数是姑息性胃切除术后IV期胃癌患者的一个重要预后因素。
Oncotarget. 2017 Apr 26;8(41):71197-71205. doi: 10.18632/oncotarget.17430. eCollection 2017 Sep 19.
6
Negative lymph node count is an independent prognostic factor for female patients with node positive breast cancer.阴性淋巴结计数是女性淋巴结阳性乳腺癌患者的独立预后因素。
Transl Cancer Res. 2020 Dec;9(12):7450-7457. doi: 10.21037/tcr-20-2351.
7
Negative lymph node count is an independent prognostic factor for patients with rectal cancer who received preoperative radiotherapy.对于接受术前放疗的直肠癌患者,阴性淋巴结计数是一个独立的预后因素。
BMC Cancer. 2017 Mar 28;17(1):227. doi: 10.1186/s12885-017-3222-8.
8
Adequate Number of Lymph Nodes Sampled May Determine Appropriate Surgical Modality for Early-Stage NSCLC: A Population-Based Real-World Study.采样淋巴结数量充足可能决定早期非小细胞肺癌的合适手术方式:一项基于人群的真实世界研究
Clin Lung Cancer. 2023 May;24(3):e141-e151. doi: 10.1016/j.cllc.2022.12.011. Epub 2022 Dec 26.
9
Lymph node status as a prognostic factor after palliative resection of primary tumor for patients with metastatic colorectal cancer.对于转移性结直肠癌患者,姑息性切除原发肿瘤后,淋巴结状态作为一个预后因素。
Oncotarget. 2017 Jul 18;8(29):48333-48342. doi: 10.18632/oncotarget.15696.
10
[The prognostic impact of number-indexes of lymph nodes in stage N1c colorectal cancer patients].[N1c期结直肠癌患者淋巴结数量指标的预后影响]
Zhonghua Yi Xue Za Zhi. 2022 May 24;102(19):1423-1429. doi: 10.3760/cma.j.cn112137-20220214-00297.

引用本文的文献

1
Risk factors for lymph node metastasis of soft tissue sarcomas of the head, neck, and extremities, and the clinical significance of negative lymph node dissection.头颈部和四肢软组织肉瘤淋巴结转移的危险因素,以及阴性淋巴结清扫的临床意义。
J Orthop Surg Res. 2022 Mar 18;17(1):167. doi: 10.1186/s13018-022-03050-3.

本文引用的文献

1
The Interval Between Preoperative Radiation and Surgery Is Not Associated with Overall Survival for Soft-tissue Sarcomas: An Analysis of the National Cancer Database.术前放疗与手术间隔时间与软组织肉瘤的总生存期无关:国家癌症数据库分析。
Clin Orthop Relat Res. 2021 Mar 1;479(3):506-517. doi: 10.1097/CORR.0000000000001287.
2
Harvest of at least 18 lymph nodes is associated with improved survival in patients with pN0 colon cancer: a retrospective cohort study.至少采集 18 枚淋巴结可改善 pN0 结直肠癌患者的生存:一项回顾性队列研究。
J Cancer Res Clin Oncol. 2020 Aug;146(8):2117-2133. doi: 10.1007/s00432-020-03212-y. Epub 2020 Apr 13.
3
Adherence to Adjuvant Imatinib Therapy in Patients with Gastrointestinal Stromal Tumor in Clinical Practice: A Cross-Sectional Study.
临床实践中胃肠道间质瘤患者对辅助伊马替尼治疗的依从性:一项横断面研究。
Chemotherapy. 2019;64(4):197-204. doi: 10.1159/000505177. Epub 2020 Jan 17.
4
Preoperative AFU Is a Useful Serological Prognostic Predictor for Colorectal Liver Oligometastasis Patients Undergoing Hepatic Resection.术前AFU是接受肝切除的结直肠癌肝寡转移患者有用的血清学预后预测指标。
J Cancer. 2019 Aug 28;10(21):5049-5056. doi: 10.7150/jca.31539. eCollection 2019.
5
Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis.手术治疗腹膜后肉瘤:基于人群的竞争风险分析。
Eur Urol Oncol. 2018 Sep;1(4):346-351. doi: 10.1016/j.euo.2018.05.008. Epub 2018 May 31.
6
Establishment and Verification of Prognostic Nomograms for Patients with Gastrointestinal Stromal Tumors: A SEER-Based Study.胃肠道间质瘤患者预后列线图的建立与验证:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Biomed Res Int. 2019 Mar 27;2019:8293261. doi: 10.1155/2019/8293261. eCollection 2019.
7
Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles.右半结肠癌、左半结肠癌和直肠癌的比较蛋白质基因组分析揭示了不同的突变特征。
Mol Cancer. 2018 Dec 21;17(1):177. doi: 10.1186/s12943-018-0923-9.
8
Surgery remains the best solution for patients with soft-tissue sarcomas.手术仍然是软组织肉瘤患者的最佳治疗方案。
CA Cancer J Clin. 2019 Jan;69(1):3-4. doi: 10.3322/caac.21464. Epub 2018 Nov 26.
9
New TNM classification (AJCC eighth edition) of bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.骨与软组织肉瘤的新TNM分类(美国癌症联合委员会第八版):日本临床肿瘤学会骨与软组织肿瘤研究组
Jpn J Clin Oncol. 2019 Feb 1;49(2):103-107. doi: 10.1093/jjco/hyy157.
10
Neoadjuvant Chemotherapy, Concurrent Chemoradiation, and Adjuvant Chemotherapy for High-Risk Extremity Soft Tissue Sarcoma.新辅助化疗、同步放化疗及辅助化疗用于高危肢体软组织肉瘤的治疗
Am Soc Clin Oncol Educ Book. 2018 May 23;38:910-915. doi: 10.1200/EDBK_201421.